- Close date
- No date set
- Academic background
- Health Sciences
- Host campus
- Pathology and Biomedical Science (Christchurch)
- Associate Professor Logan Walker
Significant ethnic disparities in cancer survival exist in New Zealand, due to contributors, such as late diagnosis, and differential access to and quality of cancer care services. Advances in cancer genetics and associated technologies have enabled health professionals to clinically diagnose individuals who are at increased risk of this disease.
Interpreting genetic test results is a major challenge for health care professionals and current methods are susceptible to ethnic biases.
This project aims to address this challenge by developing RNA-based diagnostic protocols that help determine the clinical significance of DNA sequence variants.
This study will provide an opportunity for a student to conduct research that will have both national and international significance through our leading role in international expert groups that are tasked with improving diagnostic methods.
This is one of a number of projects on offer for the 2024 intake of BBiomedSc(Hons) at the University of Otago, Christchurch campus.
Preferred student expertise
Science student with an interest in genetics and data analysis, and who has laboratory experience.
For more information
- UOC BBiomedSc(Hons) website
- Associate Professor Logan Walker's profile
- Mackenzie Cancer Research Group website
- Department of Pathology and Biomedical Science website
Similar research opportunities
- Antibiotic failure in tuberculosis due to interactions with myeloperoxidase, an enzyme released by immune cells
- Identifying the mechanism of action of a marine-derived anticancer compound
- Adipocyte markers as predictors of progression in men with prostate cancer
- Amyloids of p16 in cancer
- Analysis of the pharmacogene CYP2D6 using nanopore DNA sequencing system